SAFE vs Priced Round: How to Choose, With a Dilution Example

The mechanics, the costs, and the dilution math behind the two ways to raise early money

Comparisons12 min read
SAFE vs Priced Round: How to Choose, With a Dilution Example

In the SAFE vs priced round decision, a post-money SAFE is usually faster and cheaper and tends to suit smaller rounds with no lead asking for governance. A priced round typically costs more and takes longer, but it fixes your valuation, share count, and governance now. In our view the choice depends mostly on round size, who leads, and how much cap table certainty you want.

The data shows where the line usually falls. Carta's Q1 2026 pre-seed report found convertible notes at a record-low 7 percent of pre-seed rounds, with SAFEs making up nearly all the rest. At seed, Carta's data for the year to Q3 2024 put SAFEs at 64 percent of rounds and priced equity at 27 percent, and priced rounds took 70 percent of seed deals above $5M.

Put simply: a SAFE buys you speed now, and a priced round buys you certainty now. You pay for whichever one you skip, just later.

What is a SAFE?

A SAFE (Simple Agreement for Future Equity) is a contract in which an investor gives you money now in exchange for the right to receive shares later, when you raise a priced round. No shares are issued at signing, no valuation is formally set, and there's no interest rate or maturity date. That last part is what separates it from a convertible note.

Y Combinator created the SAFE in 2013 (it was drafted by YC's Carolynn Levy) and moved its standard deal to the post-money SAFE in September 2018. Carta's State of Pre-Seed report for 2025 describes the post-money SAFE with a valuation cap and no discount as the standard pre-seed instrument. Its key terms:

  • Valuation cap: the maximum post-money valuation at which the SAFE converts. If your next round prices higher, the SAFE holder converts at the cap and gets more shares per dollar than new investors. Carta reported median caps of $10M for rounds of $250K to $1M and $15M for rounds of $1M to $2.5M in 2025.
  • Discount: a percentage off the next round's price. YC publishes a discount-only version (Cooley GO notes discounts typically run 10 to 25 percent). YC does not publish a cap-and-discount version, but some negotiated SAFEs combine the two, in which case the investor gets whichever produces more shares.
  • MFN (most favored nation): YC's uncapped, no-discount version, which lets the holder adopt better terms if you later issue a SAFE with more favorable terms. Common with the earliest angels.
  • Pro rata side letter: the right to invest in a later round to maintain ownership. YC offers it as an optional separate letter, not part of the base SAFE.

The "post-money" part matters. Under a post-money SAFE, the investor's ownership is set at signing: $500K on a $10M post-money cap is 5 percent, regardless of how many other SAFEs you sell before the priced round. YC's documents page calls this the biggest advantage of the post-money SAFE: the ownership sold is immediately transparent and calculable for founder and investor alike.

The catch for founders? Those percentages come out of your stake. Track the total.

What is a priced round?

A priced round is a sale of preferred stock at a negotiated price per share. You and the lead investor agree on a pre-money valuation, the company issues new shares, and the cap table updates immediately. The deal starts with a term sheet, and most US priced rounds then use the NVCA model documents: a stock purchase agreement, amended certificate of incorporation, investors' rights agreement, voting agreement, and right of first refusal and co-sale agreement.

Priced rounds carry terms SAFEs don't: a liquidation preference (usually 1x non-participating at seed), board composition, protective provisions, information rights, and anti-dilution protection. Our guides to term sheets and common vs preferred stock cover these in depth.

SAFE vs priced round: side by side

Factor Post-money SAFE Priced round
Time to close Often days, since the form is standard A few weeks to a couple of months (Carta)
Legal cost Usually low, varies with how much is negotiated Carta: $40K to $120K or more all-in for seed and Series A
Valuation Cap only, shares set at conversion Price per share fixed now
Governance None by default Board seats, protective provisions

The deeper difference, as we see it, is certainty. A priced round tells everyone exactly who owns what. A SAFE defers that answer. That's efficient while the round is small, and painful if you sell many SAFEs at different caps over 18 months.

SAFE vs priced round dilution: a worked example

An illustrative example: assume you have 8,000,000 founder shares and no option pool. You raise on SAFEs first, then do a priced seed.

SAFE stage. You sell $500K of post-money SAFEs at a $5M cap (10 percent) and later $1M at a $10M cap (10 percent). Under post-money mechanics, those two investors together hold a fixed 20 percent of the company just before the priced round, and neither dilutes the other.

Priced seed. A lead offers $3M at a $12M pre-money valuation and requires a 10 percent post-money option pool created as part of the round. In this simplified example, ownership lands roughly as follows:

  • The new investor owns $3M divided by the $15M post-money, or 20 percent.
  • The option pool is 10 percent of post-money.
  • The SAFE holders' 20 percent is diluted by the new money and the pool, landing at about 14 percent combined.
  • Founders end up with about 56 percent.

Now compare: skip the SAFEs and raise the full $4.5M in one priced round at the same $12M pre-money. New investors own about 27 percent, the pool 10 percent, and founders about 63 percent.

Raising earlier on lower caps cost the founders roughly 7 percentage points. In our view that's the price of taking money before the value was proven, not a flaw in the instrument.

The practical lesson: model each SAFE in a cap table tool before you sign it, and check fully diluted ownership at the likely next round. How SAFEs impact dilution walks through more scenarios, the investor-side pre-money vs post-money SAFE guide explains the two SAFE versions, and cap table management shows how to keep the model current.

When to use a SAFE vs a priced round

When a SAFE often fits

  • The round is small. Carta's data shows a seed round up to about $2M is still more likely than not to be a SAFE, and 86 percent of seed rounds under $500K were SAFEs.
  • Speed matters. You have a customer contract to fund or a hire to make and would rather not wait two months.
  • You're raising in tranches from angels over a few months rather than all at once.
  • Valuation is genuinely uncertain, and you'd rather let the next round set the price than argue about it now.
  • You want to avoid a board at this stage. Many pre-seed investors don't want a seat anyway.

Where you can, use one cap for the whole round. If you use different caps, keep the spread narrow and record each SAFE in the same tool.

When a priced round often fits

  • A lead fund is writing a large check, often $1.5M or more, and expects a board seat and standard preferred terms.
  • The total raise is larger, roughly $2M to $3M and up, and especially above $5M, where Carta found 70 percent of seed deals were priced. Legal cost becomes a small share of the round and the certainty is often worth it.
  • You already have a stack of SAFEs and want to clean up the cap table so everyone knows what they own.
  • You're hiring senior people who want to know exactly what their options are worth. Carta notes that a priced round is typically a material event under Section 409A, so companies get an updated 409A valuation, which sets the option strike price, before issuing new grants.
  • You value the discipline. A board and formal reporting can help a team that's ready to scale.

Series A investors generally prefer a clean preferred stack, so many companies price their seed round partly to convert outstanding SAFEs before the A.

"SAFEs are simpler, so why ever price a seed?"

It's a reasonable instinct. SAFEs are cheap, fast and founder-friendly, and plenty of companies have raised their way to a Series A without a priced round.

But Simple to sign isn't the same as simple to own. Every SAFE is a claim on your company that nobody has converted yet, and a long stack of them at different caps with no lead can look, to the next investor, like a round where the bigger checks looked and passed. We treat a crowded, leaderless SAFE stack as one of the cap table flags worth explaining before someone else asks. Past a certain size, pricing the round is often the cleaner option, even after the legal bill.

Common mistakes with each instrument

Common SAFE mistakes: issuing uncapped SAFEs without an MFN and regretting it later; stacking $2M or more of SAFEs at four different caps; forgetting that post-money SAFEs do not dilute each other, so the founders absorb it; and signing pro rata side letters with everyone, which later crowds out the Series A lead.

Common priced round mistakes: accepting participating preferred or a preference above 1x at seed; agreeing to an oversized option pool in the pre-money (a hidden valuation cut); giving a small investor a board seat; and running up large legal bills on a small round because nobody insisted on standard documents.

A decision checklist

These five questions often make the choice clearer, though your situation may differ:

  1. Is the total raise under about $2M? (Yes leans SAFE.)
  2. Is there a single lead investing 50 percent or more? (Yes leans priced.)
  3. Do you need the money in the next 30 days? (Yes leans SAFE.)
  4. Do you already have more than $1.5M of SAFEs outstanding? (Yes leans priced, to clean up.)
  5. Does your lead investor require a board seat? (Yes usually means priced.)

Where we land

Whichever instrument you choose, we think your leverage comes mainly from traction, not from the document. Founders who arrive with revenue growth and a repeatable sales motion tend to get better caps and better priced terms. That's the point of Accelerate: a remote program for early-stage startups ready to grow, pairing a $100K investment (at a valuation cap of up to $3.5M) with founder-led sales training and access to a network of 850+ investors. More traction before you raise tends to improve the dilution math on each instrument in this article.

The bottom line

Small round, no lead, need it fast: a SAFE usually fits. Big check, a lead who wants a board seat, a messy stack to clean up: price it. And model the dilution either way.

The SAFE postpones the argument about price.

It doesn't cancel it.

Key takeaways

  • Post-money SAFEs are usually fast and inexpensive and fix investor ownership at signing; priced rounds cost more but set valuation, share counts, and governance now.
  • SAFEs dominate pre-seed and seed rounds up to about $2M in Carta's data; for larger rounds or a lead that wants a board seat, a priced round is common.
  • Post-money SAFEs do not dilute each other, so founders absorb the full dilution of each SAFE sold. It helps to model it before you sign.
  • Many founders aim to keep terms standard on both: one cap, a 1x non-participating preference, and no oversized pre-money option pool.
  • In our view, traction matters more than the instrument in determining your terms.

Frequently asked questions

A SAFE is a promise to issue shares in a future priced round, usually subject to a valuation cap, with no shares, board, or preferred terms today. A priced round issues preferred stock now at a fixed price per share, using a full document set that includes a term sheet and an amended charter. SAFEs trade certainty for speed and cost; priced rounds do the opposite.

Neither is better in every case, in our view. SAFEs tend to work best when the round is small, speed matters, and you want to avoid governance at pre-seed. Priced rounds tend to work best once a lead is writing a large check, the raise is bigger, or you want a clean cap table before a Series A.

Under the standard YC SAFE, the priced round triggers conversion: outstanding SAFEs convert into preferred stock at the same closing, at whichever price gives the investor more shares: the cap price or the round price (discount SAFEs convert at a discount to the round price). The SAFE holders then sit on the cap table with the new investors and are diluted by the new money and any option pool increase.

It varies with deal complexity, law firm, and how much is negotiated. Carta's guide to priced rounds puts the all-in cost of closing a priced seed or Series A at roughly $40,000 to $120,000 or more, covering legal fees, diligence, and closing work. The company usually pays reasonable investor counsel fees too, and standard NVCA-based documents help keep the bill down.

As a rule of thumb, consider switching when SAFEs outstanding reach roughly $1.5M to $3M, when a lead investor wants a board seat, or when you need a fixed share price for hiring. Many companies raise pre-seed on SAFEs and then price the seed round, which converts the SAFEs and cleans up the cap table.

Sources

Disclaimer: This guide is for general education only and is not legal, tax or investment advice. Laws, market data and program terms change, so it may not reflect the latest developments or fit your situation. Treat it as a starting point, not a source of truth, and talk to a qualified lawyer, accountant or financial adviser before you make decisions.